Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Shuguang Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, China
Taipei Veterans General Hospital, Taipei, Taiwan
The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, China
Dalian Municipal Friendship Hospital, Dalian, Liaoning, China
Renji Hospital, Shanghai, Shanghai, China
Beijing Hospital, Beijing, Beijing, China
Sanggye Paik hospital, Seoul, Korea, Republic of
Yeungnam University Medical Center, Daegu, Korea, Republic of
Zhejiang Cancer hospital, Hangzhou, Zhejiang, China
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.